Open Beta
MetriLume

US marketsIPSC

SEC-sourced researchBeta

IPSC

Century Therapeutics, Inc.

Company comparison ↗

Data passport

CIK
0001850119
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 6,589,000.0000 USD; December 2025: 109,164,000.0000 USD109.2M USD0 USD0December 2024December 2025
IPSC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20246,589,000.0000Mar 12, 2026
December 2025109,164,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025109,164,000.0000-9,580,000.0000-103,876,000.0000223,704,000.000064,768,000.0000Mar 12, 2026
December 20246,589,000.0000-126,566,000.0000-110,135,000.0000353,216,000.0000191,854,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$109.16MDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$6.59MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$9.58MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$103.88MDecember 2025Mar 12, 202610-K
Total assetsAssets$223.7MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$64.77MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗